Results 21 to 30 of about 5,715 (232)

Left ventricular aneurysm repair with concomitant septal myectomy. [PDF]

JTCVS Tech
Kindzelski B, Bloomingdale R, Hanson I, Coram R, Vivacqua A, Altshuler J, Schwann T, Suri RM.   +7 more
europepmc   +2 more sources

Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy With Anomalous Papillary Muscle Insertion. [PDF]

Interdiscip Cardiovasc Thorac Surg
Chen Y, Quintana E, Fang J, Liu Y, Wei X.   +4 more
europepmc   +3 more sources

[MSB-12] Our Clinical Experience with Septal Myectomy in Hypertrophic Cardiomyopathy Patients. [PDF]

Turk Gogus Kalp Damar Cerrahisi Derg
Akyol FB, Kadan M, Demirkıran T, Özdem T, Kubat E, Karabacak K.   +5 more
europepmc   +2 more sources

Beating-Heart Septal Myectomy: An Innovative Approach for Hypertrophic Obstructive Cardiomyopathy. [PDF]

JACC Asia
Liu L, Li J.
europepmc   +2 more sources

Early left atrial reverse remodelling in patients with hypertrophic obstructive cardiomyopathy receiving transapical beating-heart septal myectomy. [PDF]

Interdiscip Cardiovasc Thorac Surg
Lu S, Zhang J, Zhu Y, Zhou W, Cheng X, Wang H, Chen Y, Wei X, Liu Y.   +8 more
europepmc   +3 more sources

«Edge-to-edge» mitral valve repair for septal myectomy versus isolated myectomy: a pilot randomized trial

Евразийский Кардиологический Журнал, 2023
Background. Septal myectomy  is currently the «gold» standard of surgical treatment  of patients with obstructive  hypertrophic  cardiomyopathy.  In some  cases,  isolated septal myectomy does  not eliminate SAM-induced mitral insufficiency.
A. S. Zalesov, D. Y. Kozmin, S. A. Budagaev, A. V. Afanasyev, R. M. Sharifulin, S. I. Zheleznev, A. V. Bogachev-Prokophiev, A. M. Chernyavsky   +7 more
doaj   +1 more source

Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases

Journal of Cardiothoracic Surgery, 2021
Background Although septal myectomy is a standard strategy for managing patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms, so far, only a few experienced myectomy centers exist globally.
Qiang Ji, Yu Lin Wang, Ye Yang, Hao Lai, Wen Jun Ding, Li Min Xia, Chun Sheng Wang   +6 more
doaj   +1 more source

Triglyceride–Glucose Index Independently Predicts New-Onset Atrial Fibrillation After Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy Beyond the Traditional Risk Factors

Frontiers in Cardiovascular Medicine, 2021
The triglyceride–glucose index is a valuable marker of insulin resistance. However, the predictive value of this index for postoperative atrial fibrillation in patients undergoing septal myectomy remains unclear. A total of 409 patients with hypertrophic
Zhipeng Wei, Enjun Zhu, Changwei Ren, Jiang Dai, Jinhua Li, Yongqiang Lai   +5 more
doaj   +1 more source

Transmitral Septal Myectomy [PDF]

Operative Techniques in Thoracic and Cardiovascular Surgery, 2017
In patients undergoing operative intervention for hypertrophic cardiomyopathy (HCM), intrinsic abnormalities of the mitral valve may need to be addressed at the time of septal myectomy. Advantages of a transmitral approach to septal myectomy include a panoramic view of the septum and the exposure necessary to address concomitant mitral valve pathology.
Brody Wehman, James S. Gammie
openaire   +1 more source

Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy

Heart Vessels and Transplantation, 2023
Hypertrophic cardiomyopathy is a common genetic heart disease characterized predominantly by non-dilated hypertrophy of the left ventricle, in the absence of other cardiac, systemic, or metabolic diseases that can cause the observed degree of hypertrophy.
Sergei A. Budagaev, Maksat A. Zhakayev, Rustem M. Tuleutayev, Michel V. Vorontsov, Artem A. Nikitenko , Zhanar N. Nurbay, Daniyar B. Kunapyanov, Marat O. Pashimov   +7 more
doaj   +1 more source